Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States

E Smith Moland et al. Antimicrob Agents Chemother. 2003 Jul.

. 2003 Jul;47(7):2382-3.

doi: 10.1128/AAC.47.7.2382-2383.2003.

No abstract available

References

1. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298. - PubMed
1. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951. - PMC - PubMed
1. Hanson, N. D., K. S. Thomson, E. S. Moland, C. C. Sanders, G. Berthold, and R. G. Penn. 1999. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J. Antimicrob. Chemother. 44:377-380. - PubMed
1. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing; 12th informational supplement (aerobic dilution) M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
1. Saladin, M., V. T. B. Cao, T. Lambert, J.-L. Donay, J.-L. Hermann, Z. Ould-Hocine, C. Verdet, F. Delisle, A. Philippon, and G. Arlet. 2002. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209:161-168. - PubMed